| AKESO INC. O.N. |
| China |
| Gesundheit |
| KYG0146B1032 / A2P200 |
| 4RY (Frankfurt) |
| FRA:4RY, ETR:4RY, 4RY:GR |
| - |
| https://www.akesobio.com/ |
|
Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating to oncology and autoimmune disorders. As a key pla..
>Volltext.. |
| 11907.15 Mio. EUR |
| 11332.84 Mio. EUR |
| 365.45 Mio. EUR |
| -81.41 Mio. EUR |
| -132.96 Mio. EUR |
| -0.15 EUR |
| 559.13 Mio. EUR |
| 162.41 Mio. EUR |
| - |
| 4.18 |
| 26.73% |
| -90.33% |
| - |
| - |
| - |
| - |
| AKESO |
| 31.05.26 |
|
||||
|